Back
BioStem Technologies Vs. Perspective Therapeutics Industry Stock Comparison
Buy
63
BSEM
BioStem Technologies
Last Price:
17.21
Seasonality Move:
-4%
Sell
30
CATX
Perspective Therapeutics
Last Price:
3.49
Seasonality Move:
27.93%
Buy
63
BioStem Technologies (BSEM)
is a Buy
Is BioStem Technologies a Buy, Sell or Hold?
- The current BioStem Technologies [BSEM] share price is $17.21. The Score for BSEM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- BSEM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $3.48. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BSEM Stock Price Chart
What is BioStem Technologies's stock price today?
-
The BioStem Technologies share price today is $17.21
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BSEM is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight buying pressure.
BSEM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 57.09 | Buy |
| Chaikin Money Flow: | 41492 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.15 - 19.75) | Buy |
| Bollinger Bands (100): | (8.98 - 16.42) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.65 | Sell |
| Relative Strength Index (14 RSI): | 22.44 | Sell |
| Chaikin Money Flow: | 421257 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.89 - 8.29) | Sell |
| Bollinger Bands (100): | (7.6 - 15.16) | Sell |
BSEM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.58 | Buy |
| 20-day SMA: | 14.27 | Buy |
| 50-day SMA: | 15.13 | Buy |
| 200-day SMA: | 11.07 | Buy |
| 8-day EMA: | 15.78 | Buy |
| 20-day EMA: | 15.44 | Buy |
| 50-day EMA: | 14.77 | Buy |
| 200-day EMA: | 11.22 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.63 | Sell |
| 20-day SMA: | 4.4 | Sell |
| 50-day SMA: | 9 | Sell |
| 200-day SMA: | 12.37 | Sell |
| 8-day EMA: | 3.7 | Sell |
| 20-day EMA: | 4.97 | Sell |
| 50-day EMA: | 7.85 | Sell |
| 200-day EMA: | 10.37 | Sell |
BioStem Technologies Earnings Growth & BSEM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.47 per share, and an increase next year of $0.88 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
BioStem Technologies Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||